Market Research International

Global Depression Drugs Market 2015-2019

Press Release   •   Aug 11, 2015 03:13 EDT

About depression drugs
According to the WHO, depression is a common mental disorder that contributes significantly to the global burden of disease. It affects people across communities worldwide. It is characterized by sadness, loss of interest or pleasure, feelings of guilt or low self-worth, disturbed sleep or appetite, feelings of tiredness, and poor concentration. Depression can be roughly categorized into six different types. An individual with severe depression can have suicidal thoughts and behaviors. According to a 2012 estimate by the WHO, about 3,000 suicides take place each day, resulting in more than a million deaths each year. Depression can be recurrent and can be severely debilitating. Patients with mild depression can be treated with medications, but in cases of moderate or severe depression, the patient needs both medication and professional psychotherapy in the form of counseling. According to a 2008 report by the WHO, depression affects men and women equally, but women are more likely to be affected by depression than men. According to the CDC, depression can lead to many adverse behaviors in an individual such as alcoholism, smoking, and sleep disturbance. According to the CDC factsheet, in the US, one in every 10 individuals is affected by depression. According to the NIMH in the US, major depressive disorder is one of the most debilitating disorders in the US and affects about 14.80 million adults aged 18 years and above.
The report's analysts forecast the global depression drugs market to grow at a CAGR of 5.25% over the period 2014-2019.
Covered in this report
This report covers the present scenario and the growth prospects of the global depression drugs market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used for the treatment of depression. The global depression drugs market is segmented based on the mechanism of action of the drugs used to treat depression, as mentioned below:
- Tricyclic antidepressants
- Serotonin-norepinephrine reuptake inhibitors
- Selective serotonin reuptake inhibitors
- Monoamine oxidase inhibitors
- Others
This report, Global Depression Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, EMEA, and APAC; it also covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key regions
- Americas
Key vendors
- Actavis
- Bristol-Myers Squibb
- Eli Lilly
- GlaxoSmithKline
- Pfizer
Other prominent vendors

- Abbott Laboratories
- Addex Therapeutics
- Alkermes
- AstraZeneca
- Aurobindo Pharma
- Avanir Pharmaceuticals
- Cerecor
- Chugai Pharmaceutical
- Dart NeuroScience
- Dr. Reddy's Laboratories
- Edgemont Pharmaceuticals
- E-Therapeutics
- Euthymics
- Evotec
- F. Hoffmann-La Roche
- Fabre Kramer
- Gedeon Richter
- H. Lundbeck
- Intra-Cellular Therapies
- Janssen Pharmaceuticals
- Lupin
- Luye Pharma
- MSI Methylation Sciences
- Naurex
- Neuralstem
- Novartis
- Opko Health
- Otsuka Pharmaceutical
- Pierre Fabre
- Shire
- SK Biopharmaceuticals
- Somerset Pharmaceuticals
- Sun Pharmaceutical
- Sunovion Pharmaceuticals
- Suven
- Takeda Pharmaceutical
- Teva Pharmaceutical
- Torrent Pharmaceuticals
- Valeant Pharmaceuticals
Market driver
- Rise in patient population
- For a full, detailed list, view our report
Market challenge
- Threat of expiry of patents
- For a full, detailed list, view our report
Market trend
- Growing public awareness
- For a full, detailed list, view our report
Key questions answered in this report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Market Research International is a leading distributor of PREMIUM market research reports.